USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CANCER GENETICS, INC.
City: Rutherford
State: NJ
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $896,267.00 7
SBIR Phase II $1,709,016.00 3

Award List:

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ramana V. Tantravahi
Award Amount: $132,371.00

FISH ASSAY FOR THE DETECTION OF T (14;18) (Q32;21)

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ramana V. Tantravahi
Award Amount: $0.00
Abstract:
DESCRIPTION (applicant's abstract): Approximately 60 percent of B-cell lymphomas are characterized by the presence of the t(14;18) (q32;q21) chromosomal translocation. Diagnosis and post-treatment follow-up are currently performed by karyotype, Southern blotting, or… More

FISH ASSAY FOR THE DETECTION OF T (14;18) (Q32;21)

Award Year / Program / Phase: 2001 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ramana V. Tantravahi
Award Amount: $417,956.00
Abstract:
DESCRIPTION (applicant's abstract): Approximately 60 percent of B-cell lymphomas are characterized by the presence of the t(14;18) (q32;q21) chromosomal translocation. Diagnosis and post-treatment follow-up are currently performed by karyotype, Southern blotting, or… More

MOLECULAR PROBES FOR BURKITT'S AND MANTLE CELL LYMPHOMA

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nallasivam Palanisamy
Award Amount: $158,425.00
Abstract:
APPLICANT?S DESCRIPTION: The goal of this research is to develop two fluorescence in situ hybridization (FISH) assays for the detection of the t(11;14)(q13;q32) and the t(8;14)(q24;q32) chromosomal translocations encountered in Mantle and Burkitt?s B-cell Lymphoma respectively. These tumors are… More

FISH Assay for Acute Myeloid Leukemia

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nallasivam Palanisamy
Award Amount: $226,508.00
Abstract:
DESCRIPTION (Applicant's abstract): The goal of this research is to develop two fluorescence in situ hybridization (FISH) assays for detecting the t(8;21)(q22;q22) and inv(16)(p13q22) and related t(16;16)(p13;q22) translocations found in two different subsets… More

HIGH THROUGHPUT SYSTEM FOR FISH ANALYSIS

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nallasivam Palanisamy
Award Amount: $186,145.00
Abstract:
Minimum Residual Disease (MRD) is currently identified using pathologic examination, cytogenetics, fluorescence activated cell sorting, and polymerase chain reaction (PCR). Pathologic examination, which assesses cancer cell morphology, is the standard method, but the detection limit is only 10/-1 to… More

Development and Validation of a FISH-Based Renal Cancer Detection Assay

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $93,253.00
Abstract:
DESCRIPTION (provided by applicant): Increased routine use of state-of-the-art imaging techniques has resulted in a higher incidence of small incidentally discovered renal masses, benign and malignant. A large proportion of patients with such masses, are w ithin an older, more frail population and… More

Development of a FISH-Based HPV-Associated Cancer Detection Test

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jane Houldsworth
Award Amount: $99,565.00
Abstract:
DESCRIPTION (provided by applicant): A causative role of high-risk human papillomavirus (HPV) types in human cancer has been established, particularly for those of the anogenital region including cervical and anal cancers. The etiologic course of such canc ers is thought to involve HPV infection,… More

Development and Validation of a FISH-Based Renal Cancer Detection Assay

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Jane Houldsworth
Award Amount: $645,168.00
Abstract:
DESCRIPTION (provided by applicant): Increased routine use of state-of-the-art imaging techniques has resulted in a higher incidence of small incidentally discovered renal masses, benign and malignant. A large proportion of patients with such masses, are w ithin an older, more frail population and… More

Development of a FISH-Based HPV-Associated Cancer Detection Test

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Jane Houldsworth – 201-528-9171
Award Amount: $645,892.00
Abstract:
DESCRIPTION (provided by applicant): A causative role of high-risk human papillomavirus (HPV) types in human cancer has been established, particularly for those of the anogenital region including cervical and anal cancers. The etiologic course of such cancers is thought to involve HPV infection,… More